Minutes - PDCO minutes of the 17-20 June 2025 meeting

Veterinary medicines European public assessment report (EPAR): Felisecto Plus, selamectin,sarolaner, Date of authorisation: 26/04/2019, Revision: 2, Status: Withdrawn

Human medicines European public assessment report (EPAR): Revolade, eltrombopag, Date of authorisation: 11/03/2010, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Iscover, clopidogrel, Date of authorisation: 14/07/1998, Revision: 53, Status: Authorised

Human medicines European public assessment report (EPAR): Dimethyl fumarate Accord, dimethyl fumarate, Date of authorisation: 22/04/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Zykadia, ceritinib, Date of authorisation: 06/05/2015, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Klisyri, tirbanibulin, Date of authorisation: 16/07/2021, Revision: 4, Status: Authorised

Assessment templates and guidance

Development of the Clinical Trials Information System